Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration Beyond One Year of Treatment: AZURE, a Randomized Trial of Treat-and-Extend vs. Fixed Dosing

被引：0
|
作者：
Laurent Kodjikian
Lluís Arias Barquet
András Papp
Peter J. Kertes
Edoardo Midena
Jan Ernest
Rufino Silva
Thomas Schmelter
Tobias Niesen
Sergio Leal
机构：
[1] Croix-Rousse Teaching Hospital,Department of Ophthalmology
[2] Hospices Civils de Lyon,UMR
[3] Université Claude Bernard Lyon 1,CNRS 5510 Matéis, Villeurbanne
[4] University of Lyon,Department of Ophthalmology
[5] Hospital Universitario de Bellvitge,Department of Ophthalmology
[6] University of Barcelona,Department of Ophthalmology
[7] Semmelweis University,Department of Ophthalmology and Vision Sciences
[8] The John and Liz Tory Eye Centre,Department of Ophthalmology
[9] Sunnybrook Health Sciences Centre,Coimbra Institute for Clinical and Biomedical Research Faculty of Medicine (iCBR
[10] University of Toronto,FMUC)
[11] University Hospital,Ophthalmology Department
[12] Axon Clinical Research Center,undefined
[13] University of Coimbra,undefined
[14] Centro Hospitalar e Universitário de Coimbra (CHUC),undefined
[15] Association for Innovation and Biomedical Research on Light and Image (AIBILI),undefined
[16] Clinical Academic Center of Coimbra (CACC),undefined
[17] Bayer AG,undefined
[18] Bayer Consumer Care AG,undefined
来源：
Advances in Therapy | 2024年 / 41卷
关键词：
Anatomic outcomes; Anti-vascular endothelial growth factor; Fixed dosing; Functional outcomes; Intravitreal aflibercept; Neovascular age-related macular degeneration; Treat-and-extend; Treatment burden; Treatment interval;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1010 / 1024
页数：14
相关论文
共 50 条
  • [41] Vascular density in age-related macular degeneration after one year of antiVEGF treatment with treat-and-extend and fixed regimens
    Resch, Miklos D.
    Balogh, Aniko
    Deak, Gabor Gy
    Nagy, Zoltan Z.
    Papp, Andras
    PLOS ONE, 2020, 15 (02):
  • [42] Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration
    Hidetaka Matsumoto
    Takashi Hiroe
    Masahiro Morimoto
    Kensuke Mimura
    Arisa Ito
    Hideo Akiyama
    Japanese Journal of Ophthalmology, 2018, 62 : 144 - 150
  • [43] Efficacy of treat-and-extend regimen with aflibercept for pachychoroid neovasculopathy and Type 1 neovascular age-related macular degeneration
    Matsumoto, Hidetaka
    Hiroe, Takashi
    Morimoto, Masahiro
    Mimura, Kensuke
    Ito, Arisa
    Akiyama, Hideo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2018, 62 (02) : 144 - 150
  • [44] One-year results of treat-and-extend regimen with intravitreal brolucizumab for treatment-naive neovascular age-related macular degeneration with type 1 macular neovascularization
    Matsumoto, Hidetaka
    Hoshino, Junki
    Mukai, Ryo
    Nakamura, Kosuke
    Akiyama, Hideo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [45] Intravitreal aflibercept for neovascular age-related macular degeneration
    Xu, David
    Kaiser, Peter K.
    IMMUNOTHERAPY, 2013, 5 (02) : 121 - 130
  • [46] Two-Year Outcomes of a Treat-and-Extend Regimen Using Intravitreal Aflibercept Injections for Typical Age-Related Macular Degeneration
    Ito, Arisa
    Matsumoto, Hidetaka
    Morimoto, Masahiro
    Mimura, Kensuke
    Akiyama, Hideo
    OPHTHALMOLOGICA, 2017, 238 (04) : 236 - 242
  • [47] Clinical outcome of a modified treat-and-extend protocol in the treatment of neovascular age-related macular degeneration
    Vofo, Brice Nguedia
    Cnaany, Yaacov
    Chowers, Itay
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [48] Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration
    Aki Kato
    Tsutomu Yasukawa
    Iichiro Sugita
    Munenori Yoshida
    Miho Nozaki
    Yoshio Hirano
    Junko Kondo
    Tomohiro Abe
    Kimiko Sugita
    Takahide Okita
    Hiroshi Morita
    Noriaki Takase
    Yuichiro Ogura
    Advances in Therapy, 2022, 39 : 1403 - 1416
  • [49] Three-year outcomes of a treat and extend regimen of aflibercept for neovascular age-related macular degeneration
    Hosokawa, Mio
    Morizane, Yuki
    Kimura, Shuhei
    Shiode, Yusuke
    Hirano, Masayuki
    Doi, Shinichiro
    Toshima, Shinji
    Takahashi, Kosuke
    Fujiwara, Atsushi
    Kanzaki, Yuki
    Hosogi, Mika
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [50] Five-year Outcome of Aflibercept Administration with "Treat and Extend" for Neovascular Age-Related Macular Degeneration
    Wada, Iori
    Oshima, Yuji
    Fukuda, Yosuke
    Shiose, Satomi
    Kano, Kumiko
    Ishikawa, Keijiro
    Nakao, Shintaro
    Kaizu, Yoshihiro
    Hasegawa, Eiichi
    Kannan, Ram
    Ishibashi, Tatsuro
    Sonoda, Koh-Hei
    CLINICAL OPHTHALMOLOGY, 2025, 19 : 835 - 845
12345